| 1 | Boston Medical Center Corporation | 14 | 5/5 | 4 | $61,587 |
| 2 | Brigham and Women's Hospital | 14 | 3/5 | 0 | $93,350 |
| 3 | General Hospital Corporation | 14 | 5/5 | 1 | $85,950 |
| 4 | Biogen, Inc. | 12 | 3/5 | 0 | $203,819 |
| 5 | Mass General Brigham Incorporated | 10 | 3/5 | 0 | $125,000 |
| 6 | Takeda Development Center Americas, Inc. | 10 | 4/5 | 1 | $187,000 |
| 7 | Alnylam US, Inc. | 6 | 4/5 | 1 | $186,000 |
| 8 | Children's Hospital Corporation | 5 | 2/5 | 1 | $112,000 |
| 9 | The Broad Institute, Inc. | 5 | 2/5 | 0 | $150,000 |
| 10 | Ultragenyx Pharmaceutical, Inc. | 5 | 2/5 | 0 | $161,595 |
| 11 | Amgen Inc. | 4 | 3/5 | 2 | $179,500 |
| 12 | Northeastern University | 4 | 2/5 | 0 | $122,886 |
| 13 | Tufts Medical Center, Inc. | 4 | 3/5 | 2 | $94,597 |
| 14 | Vertex Pharmaceuticals Incorporated | 4 | 3/5 | 2 | $242,913 |
| 15 | Alexion Pharmaceuticals, Inc. | 3 | 1/5 | 0 | $161,600 |
| 16 | Arcaea, LLC | 3 | 3/5 | 0 | $200,000 |
| 17 | Beth Israel Deaconess Medical Center, Inc. | 3 | 3/5 | 0 | $110,011 |
| 18 | Bristol-Myers Squibb Company | 3 | 3/5 | 0 | $210,500 |
| 19 | Harvard University | 3 | 2/5 | 0 | $181,938 |
| 20 | Miltenyi Biomedicine, Inc. | 3 | 3/5 | 0 | $203,819 |
| 21 | Prime Medicine, Inc. | 3 | 2/5 | 0 | $210,000 |
| 22 | Sana Biotechnology, Inc. | 3 | 3/5 | 0 | $220,000 |
| 23 | Spaulding Rehabilitation Hospital | 3 | 2/5 | 0 | $95,000 |
| 24 | Syneos Health US, Inc. | 3 | 3/5 | 0 | $208,000 |
| 25 | Takeda Pharmaceuticals USA, Inc. | 3 | 2/5 | 0 | $239,200 |
| 26 | Thermo Fisher Scientific Inc. | 3 | 2/5 | 0 | $161,595 |
| 27 | University of Massachusetts Chan Medical School | 3 | 2/5 | 0 | $94,556 |
| 28 | BlueRock Therapeutics LP | 3 | 2/5 | 1 | $215,000 |
| 29 | Tango Therapeutics, Inc. | 3 | 2/5 | 2 | $610,000 |
| 30 | ModernaTX, Inc. | 3 | 3/5 | 1 | $262,122 |
| 31 | TransUnion LLC | 3 | 3/5 | 1 | $173,486 |
| 32 | 2seventy bio, inc | 2 | 1/5 | 0 | $163,298 |
| 33 | Azzur Group LLC | 2 | 1/5 | 0 | $216,320 |
| 34 | Brigham and Women's Physicians Organization, Inc | 2 | 1/5 | 0 | $200,000 |
| 35 | CRISPR Therapeutics, Inc. | 2 | 2/5 | 1 | $251,092 |
| 36 | Curiox Biosystems, Inc. | 2 | 2/5 | 0 | $140,600 |
| 37 | Dyne Therapeutics, Inc. | 2 | 2/5 | 1 | $185,625 |
| 38 | Elucid Bioimaging Inc. | 2 | 1/5 | 0 | $285,000 |
| 39 | Garuda Therapeutics, Inc. | 2 | 2/5 | 0 | $272,924 |
| 40 | Harbinger Health, Inc. | 2 | 1/5 | 0 | $360,000 |
| 41 | Institute for Protein Innovation Inc. | 2 | 2/5 | 1 | $222,794 |
| 42 | IQVIA RDS Inc. | 2 | 2/5 | 0 | $131,409 |
| 43 | Magenta Therapeutics, Inc. | 2 | 2/5 | 0 | $170,800 |
| 44 | PPD Development, L.P. | 2 | 1/5 | 0 | $182,539 |
| 45 | Precision Development, Inc. | 2 | 2/5 | 0 | $169,000 |
| 46 | Scholar Rock, Inc., subsidiary of Scholar Rock Holding Corporation | 2 | 1/5 | 0 | $183,000 |
| 47 | Smithsonian Institution | 2 | 2/5 | 0 | $216,000 |
| 48 | TRUSTEES OF BOSTON UNIVERSITY | 2 | 1/5 | 0 | $71,569 |
| 49 | Verve Therapeutics, Inc. | 2 | 1/5 | 0 | $140,795 |
| 50 | Voiant, LLC | 2 | 2/5 | 1 | $134,000 |
| 51 | EMD Serono Research and Development Institute, Inc. | 2 | 2/5 | 0 | $260,000 |
| 52 | ProQR Therapeutics I Inc. | 2 | 1/5 | 0 | $311,436 |
| 53 | Active Site Research, Inc. | 1 | 1/5 | 1 | $130,000 |
| 54 | Aditum Bio Services, Inc. | 1 | 1/5 | 0 | $300,000 |
| 55 | Aera Therapeutics Inc. | 1 | 1/5 | 0 | $200,000 |
| 56 | AIR Worldwide Corporation | 1 | 1/5 | 1 | $184,483 |
| 57 | Akebia Therapeutics, Inc. | 1 | 1/5 | 0 | $168,717 |
| 58 | Ananke Therapeutics, Inc. | 1 | 1/5 | 0 | $222,375 |
| 59 | Ardelyx, Inc. | 1 | 1/5 | 1 | $235,102 |
| 60 | Ash Stevens, LLC | 1 | 1/5 | 0 | $199,909 |
| 61 | Axonis Therapeutics, Inc. | 1 | 1/5 | 0 | $175,000 |
| 62 | Baystate Medical Center, Inc. | 1 | 1/5 | 0 | $79,206 |
| 63 | Beam Therapeutics, Inc. | 1 | 1/5 | 1 | $280,000 |
| 64 | Bicycle Therapeutics, Inc. | 1 | 1/5 | 0 | $180,000 |
| 65 | Blueprint Medicines Corporation | 1 | 1/5 | 0 | $128,535 |
| 66 | Boston College | 1 | 1/5 | 0 | $93,150 |
| 67 | Caerus US 1 Inc. | 1 | 1/5 | 1 | $195,000 |
| 68 | Cambridge Mobile Telematics, Inc. | 1 | 1/5 | 0 | $162,000 |
| 69 | Collabera LLC | 1 | 1/5 | 0 | $208,000 |
| 70 | Collegium Pharmaceutical | 1 | 1/5 | 0 | $275,000 |
| 71 | Commonwealth Cancer Consortium Inc. | 1 | 1/5 | 0 | $125,000 |
| 72 | Constellation Pharmaceuticals, Inc. | 1 | 1/5 | 0 | $120,000 |
| 73 | Curis, Inc. | 1 | 1/5 | 0 | $262,948 |
| 74 | Dana-Farber Cancer Institute | 1 | 1/5 | 0 | $142,469 |
| 75 | Degron Therapeutics Co. | 1 | 1/5 | 0 | $250,000 |
| 76 | Elektrofi, Inc. | 1 | 1/5 | 0 | $145,000 |
| 77 | ElevateBio Technologies, Inc. | 1 | 1/5 | 0 | $162,000 |
| 78 | Emergent BioSolutions Inc. | 1 | 1/5 | 0 | $225,014 |
| 79 | Exai Bio, Inc. | 1 | 1/5 | 0 | $250,000 |
| 80 | Fulcrum Therapeutics, Inc. | 1 | 1/5 | 0 | $300,000 |
| 81 | GALDERMA LABORATORIES L.P. | 1 | 1/5 | 0 | $208,000 |
| 82 | Genentech, Inc. | 1 | 1/5 | 0 | $208,000 |
| 83 | GeoMali, Inc. | 1 | 1/5 | 0 | $221,707 |
| 84 | Gilgamesh Pharmaceuticals, Inc. | 1 | 1/5 | 0 | $270,000 |
| 85 | Ginkgo Bioworks, Inc. | 1 | 1/5 | 0 | $145,000 |
| 86 | HARVARD MEDICAL FACULTY PHYSICIANS AT BETH ISRAEL DEACONESS MEDICAL CE | 1 | 1/5 | 0 | $205,000 |
| 87 | HARVARD MEDICAL FACULTY PHYSICIANS AT BETH ISRAEL DEACONESS MEDICAL CENTER | 1 | 1/5 | 0 | $221,708 |
| 88 | Insmed Incorporated | 1 | 1/5 | 1 | $214,200 |
| 89 | Intrinsic Foundries, Inc. | 1 | 1/5 | 1 | $235,102 |
| 90 | Jaryeefine LLC | 1 | 1/5 | 1 | $193,000 |
| 91 | Keros Therapeutics | 1 | 1/5 | 0 | $300,000 |
| 92 | Kymera Therapeutics, Inc. | 1 | 1/5 | 1 | $230,000 |
| 93 | LEAD EXPOSURE ELIMINATION PROJECT INC | 1 | 1/5 | 0 | $79,206 |
| 94 | Lyndra Therapeutics, Inc. | 1 | 1/5 | 0 | $155,000 |
| 95 | Marengo Therapeutics, Inc. | 1 | 1/5 | 0 | $240,000 |
| 96 | Massachusetts Eye and Ear Infirmary | 1 | 1/5 | 0 | $95,200 |
| 97 | Merck Sharp & Dohme Corp. | 1 | 1/5 | 0 | $161,595 |
| 98 | Metro International Biotech, LLC | 1 | 1/5 | 0 | $140,000 |
| 99 | Moderna Services, Inc. | 1 | 1/5 | 0 | $239,200 |
| 100 | Molecular Loop Biosciences, Inc. | 1 | 1/5 | 0 | $208,000 |